ADVERTISEMENT
Manila Bulletin devider Philippines devider 677 Muntinlupa residents get Pfizer jabs

677 Muntinlupa residents get Pfizer jabs

Published May 15, 2021 06:41 pm

A total of 677 residents in Muntinlupa City were inoculated with the Pfizer-BioNTech COVID-19 vaccine.

The Muntinlupa City government received 1,170 vials, or equivalent to 7,020 doses, of the Pfizer-BioNTech vaccine from the national government Thursday.

Muntinlupa Mayor Jaime Fresnedi (right) on Saturday visited the Ayala Malls South Park to observe the vaccination of residents with the Pfizer-BioNTech COVID-19 vaccine. With him is City Health Office chief Dr. Juancho Bunyi (2nd from right) (Muntinlupa PIO / MANILA BULLETIN)


On the first day of the rollout of Pfizer-BioNTech vaccine in the city, 677 residents belonging to the A3 priority group, or persons with comorbidities, were inoculated.

The initial supply of the vaccine will be used by the city government from May 14 to 18 at its vaccination site at Ayala Malls South Park, the only venue approved by the Department of Health (DOH) due to handling requirements for Pfizer-BioNTech.

Before dilution, the vaccine needs to be stored at a temperature of -80 to -60 degrees Celsius.

After dilution, each vial of Pfizer-BioNTech vaccine contains six doses of 0.3 mL each.

According to the Food and Drug Administration (FDA), the vaccine is administered in two doses three weeks apart and is for people 16 years old and above.

The vaccine needs to be administered “within six hours from the time of dilution.”

Data from the Muntinlupa City Health Office (CHO) showed that as of May 14, a total of 29,436 residents have been vaccinated with their first dose.

Of the total, 5,171, or 17.57 percent, were health workers (A1); 5,400, or 18.34 percent, senior citizens (A2); and 18,817, or 63.93 percent, were persons with comorbidities (A3); and 48, or 0.16 percent, were A4, who are overseas Filipino workers sent by the Department of Labor and Employment (DOLE) last May 1 during the Labor Day celebration.

By vaccine brand, 21,598 residents, or 73.37 percent, were given Sinovac Life Sciences’ CoronaVac; 4,182, or 14.21 percent, received AstraZeneca; 2,979 were administered the Sputnik V; and 677 were inoculated with Pfizer-BioNTech vaccine.

In addition, 9,399 residents also received their second dose of the vaccine using CoronaVac. Of the total, 1,772, or 18.85 percent, belonged to A1; 2,534, or 26.96 percent, were A2; 4,664, or 49.62 percent, were A3; and three, or 0.03 percent, were A4; and the remaining 426, or 4.53 percent, were administered at a hospital.

In total, 38,835 first and second doses have been administered in Muntinlupa.

As of May 15, Muntinlupa has 12,239 confirmed COVID-19 cases including 10,862 recoveries and 324 deaths, leaving 1,053 active cases.

Related Tags

Muntinlupa Pfizer covid-19 PFIZER BIONTECH vaccine
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.